Chelsea L. Collins

Chelsea L. Collins, MD, MS is an Assistant Professor in the Pediatric Hematology and Oncology Division of the School of Medicine at Loma Linda University. Her academic work focuses on pediatric cancer care, particularly for adolescents and young adults, with expertise in leukemia and sarcomas.

Dr. Collins' research interests center on improving cancer outcomes for adolescents and young adults through better clinical trial enrollment and understanding treatment patterns. Her work investigates healthcare disparities in cancer care, survival rates across different demographic groups, and innovative treatment approaches for difficult-to-treat cancers. She has particular expertise in cardiac sarcomas and the application of oral etoposide therapy for unresectable tumors.

Her publication record demonstrates consistent focus on adolescent and young adult oncology, with trends showing progression from case studies of rare conditions to population-based analyses of cancer care patterns. Her work spans multiple disciplines including clinical oncology, epidemiology, and healthcare delivery research, with a strong emphasis on translating findings to improve patient outcomes.

Dr. Collins serves as Principal Investigator for numerous research projects, primarily through the Children's Oncology Group, focusing on various pediatric cancer protocols including leukemia, lymphoma, sarcoma, and neuroblastoma. Her grant portfolio demonstrates significant involvement in both national cooperative group trials and industry-sponsored clinical research.

She is actively involved in multiple research teams studying pediatric blood cancers and solid tumors, with particular focus on clinical trial design and implementation for adolescents and young adults with cancer. Her laboratory work, while primarily clinical trial-focused, contributes to understanding treatment response patterns and survival outcomes in pediatric oncology patients.